Please provide your email address to receive an email when new articles are posted on . Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the Eagle device for selective laser trabeculoplasty. Laser energy is delivered in a noncontact ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager ™ DSLT, the ...

A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option. Neil Minkoff, MD: As we move into different types of therapy, laser ...

As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...

ALISO VIEJO, Calif., December 03, 2025--(BUSINESS WIRE)--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that ...